18F-Fluorodeoxyglucose PET/CT in Langerhans cell histiocytosis: spectrum of manifestations.

Jpn J Radiol

Diagnostic Nuclear Medicine Division, Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, 110029, India.

Published: April 2016

The objective of this article is to provide an illustrative tutorial highlighting the utility of 18F-FDG PET/CT imaging to detect the spectrum of manifestations in patients with Langerhans cell histiocytosis. FDG PET/CT is a powerful tool for making an early diagnosis; it allows higher diagnostic confidence with regard to lesions, measuring the extent of disease (staging) and assessing disease activity, and is consequently useful for evaluating the response to therapy in patients with Langerhans cell histiocytosis.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11604-016-0517-7DOI Listing

Publication Analysis

Top Keywords

langerhans cell
12
cell histiocytosis
12
spectrum manifestations
8
patients langerhans
8
18f-fluorodeoxyglucose pet/ct
4
pet/ct langerhans
4
histiocytosis spectrum
4
manifestations objective
4
objective article
4
article provide
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!